Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review-Reference-Cited by-同舟云学术

Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review

Published:2019-03-05 Issue:5 Volume:39 Page:933-941
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Soh Han Jie^ORCID,Samuel Courtney^ORCID,Heaton Victoria^ORCID,Renton William Douglas^ORCID,Cox Angela^ORCID,Munro Jane^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-019-04269-w.pdf

Reference38 articles.

1. Wollina U, Buslau M, Petrov I, Pramatarov K (2007) Disabling pansclerotic morphea of childhood. Expert Rev Dermatol 2:775–784

2. Diaz Perez JL, Connolly SM, Winkelmann RK (1980) Disabling pansclerotic morphea of children. Arch Dermatol 116:169–173

3. Dasgupta MK, Patra C, Sarkar S, Das S (2014) Pansclerotic morphea: a male child with hemiatrophy of lower limb. Indian Dermatol Online J 5:170–172

4. Forsea AM, Cretu AN, Ionescu R, Giurcaneanu C (2008) Disabling pansclerotic morphea of childhood—unusual case and management challenges. J Med Life 1:348–354

5. Kura M, Jindal S (2013) Disabling pansclerotic morphea of childhood with extracutaneous manifestations. Indian J Dermatol 58:159

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single‐center experience;International Journal of Rheumatic Diseases;2024-08

2. Assessment of serum and cutaneous JAK3 in juvenile scleroderma;The Egyptian Journal of Pediatric Allergy and Immunology;2024-04-01

3. Morphoea and Allied Scarring and Sclerosing Inflammatory Dermatoses;Rook's Textbook of Dermatology;2024-03-19

4. Zirkumskripte Sklerodermie im Kindesalter;Die Dermatologie;2024-01-19

5. Recent Advances in Treatment of Systemic Sclerosis and Morphea;American Journal of Clinical Dermatology;2023-12-12